Tag: Actemra/RoActemra (tocilizumab)

March 24, 2020 Off

Roche testing with BARDA Actemra’s potential utility in severe COVID-19 pneumonia patients. Working on availability of COVID 19-tests.

Roche said Tuesday it started testing Actemra (tocilizumab) with the Biomedical Advanced Research and Development Authority (BARDA)on top of standard of care in hospitalised adult patients with severe COVID-19 pneumonia compared to placebo on top of standard of care.

May 25, 2017 Off

FDA OK’s Roche’s arteritis drug

By Dino Mustafić

The U.S. Food and Drug Administration (FDA) has approved Roche’s Actemra/RoActemra (tocilizumab) subcutaneous injection for the treatment of GCA, a chronic and severe autoimmune condition.